Under emergency use authorization, the U.S. Food and Drug Administration has expanded eligibility for the Pfizer-BioNTech COVID-19 booster vaccine to children 5 to 11 years old. People in that age group are now cleared for a single booster dose of the shot at least five months after they’ve completed the primary two-dose series.
FDA expands eligibility for Pfizer COVID-19 booster to children 5-11
